Bonsity™ (teriparatide) – New drug approval
October 7, 2019 - Pfenex announced the FDA approval of Bonsity (teriparatide), for the treatment of osteoporosis in postmenopausal women, in men with primary or hypogonadal osteoporosis, and in men and women with osteoporosis associated with glucocorticoid therapy.
Top